eFFECTOR Therapeutics, Inc.

EFTRW

EFTRWeFFECTOR Therapeutics, Inc. US flag

NASDAQ Capital Market

0.00

USD

+0.00

(-80.00%)

-0.90EPS

0.00P/E

-NaNMarket Cap

Mar 31Next Earn

Income Statement	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	42	- -	- -	- -
+ Sales & Services Revenue	42	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	-42	- -	- -	- -
- Operating Expenses	26	32	32	34
+ Selling, General & Admin	4	13	13	11
+ Research & Development	22	20	23	23
+ Other Operating Expense	- -	-1	-4	- -
Operating Income (Loss)	16	-32	-32	-34
- Non-Operating (Income) Loss	1	-48	-10	2
+ Interest Expense, Net	1	2	2	2
+ Interest Expense	1	2	2	3
- Interest Income	- -	- -	- -	1
+ Other Non-Op (Income) Loss	- -	-49	-12	- -
Pretax Income	15	16	-23	-36
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	14	16	-23	-36
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	14	16	-23	-36
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	14	16	-23	-36
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	14	16	-23	-36
Basic Weighted Avg Shares	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -
Diluted Weighted Avg Shares	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -
EBITDA	16	-32	-32	-34
EBITDA Margin (%)	38.05	- -	- -	- -
EBITA	16	-32	-32	-34
EBIT	16	-32	-32	-34
Gross Margin (%)	100	- -	- -	- -
Operating Margin (%)	37.66	- -	- -	- -
Profit Margin (%)	33.84	- -	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -

Balance Sheet	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	17	53	28	20
+ Cash, Cash Equivalents & STI	15	50	26	18
+ Cash & Cash Equivalents	15	50	9	15
+ ST Investments	- -	- -	18	3
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	1	3	2	1
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	- -	1	1	1
+ Property, Plant & Equip, Net	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	1	1
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	1	1	1
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	1	1	1
Total Assets	17	54	29	21
+ Payables & Accruals	2	3	3	4
+ Accounts Payable	- -	1	1	2
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	1	2	2	1
+ ST Debt	6	- -	20	21
+ ST Borrowings	6	- -	20	20
+ ST Finance Leases	- -	- -	- -	- -
+ Other ST Liabilities	1	1	1	2
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	1	1	1	2
Total Current Liabilities	9	4	25	26
+ LT Debt	7	20	- -	- -
+ LT Borrowings	7	20	- -	- -
+ LT Finance Leases	- -	- -	- -	- -
+ Other LT Liabilities	133	13	- -	1
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	133	13	- -	1
Total Noncurrent Liabilities	140	33	- -	1
Total Liabilities	149	37	25	26
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	4	138	147	174
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	4	138	147	174
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-137	-121	-144	-179
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-132	17	4	-6
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-132	17	4	-6
Total Liabilities & Equity	17	54	29	21
Shares Outstanding	2	2	2	3
Capital Leases - Total	- -	- -	- -	- -
Net Debt	-2	-30	11	6
Net Debt to Equity	1.79	-172.66	293.97	-96.81
Tangible Common Equity Ratio	-791.7	31.97	13.4	-28.21
Current Ratio	1.89	13.3	1.12	0.77
Cash Conversion Cycle	- -	- -	- -	- -
Number of Employees	- -	- -	- -	- -

Cash Flow Statement	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	14	16	-23	-36
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	- -	-40	-6	4
+ Stock-Based Compensation	- -	9	5	5
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	-49	-11	- -
+ Chg in Non-Cash Work Cap	-1	- -	3	2
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	-1	2	1
+ Inc (Dec) in Accts Payable	-1	2	1	1
+ Inc (Dec) in Other	- -	-1	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	14	-25	-26	-30
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	1	- -	- -
+ Disp of Fixed Prod Assets	- -	1	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	-18	15
+ Dec in LT Investment	- -	- -	35	32
+ Inc in LT Investment	- -	- -	-52	-17
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	- -	1	-18	14
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	-2	6	- -	- -
+ Cash From Debt	- -	20	- -	- -
+ Repayments of Debt	-2	-14	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	3	21
+ Increase in Capital Stock	- -	- -	3	21
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Other Financing Activities	- -	53	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	-2	59	3	21
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	12	34	-41	6
Capital Expenditures	- -	- -	- -	- -
EBITDA	16	-32	-32	-34
EBITDA Margin (%)	38.05	- -	- -	- -
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow	14	-25	-26	-30
Free Cash Flow to Firm	15	-23	- -	- -
Free Cash Flow to Equity	- -	-18	-26	-30
Free Cash Flow per Basic Share	- -	- -	- -	- -
Price/Free Cash Flow	- -	- -	- -	- -
Cash Flow to Net Income	0.97	-1.58	1.14	0.83

Income Statement	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	42	- -	- -	- -
+ Sales & Services Revenue	42	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	-42	- -	- -	- -
- Operating Expenses	26	32	32	34
+ Selling, General & Admin	4	13	13	11
+ Research & Development	22	20	23	23
+ Other Operating Expense	- -	-1	-4	- -
Operating Income (Loss)	16	-32	-32	-34
- Non-Operating (Income) Loss	1	-48	-10	2
+ Interest Expense, Net	1	2	2	2
+ Interest Expense	1	2	2	3
- Interest Income	- -	- -	- -	1
+ Other Non-Op (Income) Loss	- -	-49	-12	- -
Pretax Income	15	16	-23	-36
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	14	16	-23	-36
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	14	16	-23	-36
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	14	16	-23	-36
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	14	16	-23	-36
Basic Weighted Avg Shares	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -
Diluted Weighted Avg Shares	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -
EBITDA	16	-32	-32	-34
EBITDA Margin (%)	38.05	- -	- -	- -
EBITA	16	-32	-32	-34
EBIT	16	-32	-32	-34
Gross Margin (%)	100	- -	- -	- -
Operating Margin (%)	37.66	- -	- -	- -
Profit Margin (%)	33.84	- -	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -

Balance Sheet	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	17	53	28	20
+ Cash, Cash Equivalents & STI	15	50	26	18
+ Cash & Cash Equivalents	15	50	9	15
+ ST Investments	- -	- -	18	3
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	1	3	2	1
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	- -	1	1	1
+ Property, Plant & Equip, Net	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	1	1
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	1	1	1
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	1	1	1
Total Assets	17	54	29	21
+ Payables & Accruals	2	3	3	4
+ Accounts Payable	- -	1	1	2
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	1	2	2	1
+ ST Debt	6	- -	20	21
+ ST Borrowings	6	- -	20	20
+ ST Finance Leases	- -	- -	- -	- -
+ Other ST Liabilities	1	1	1	2
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	1	1	1	2
Total Current Liabilities	9	4	25	26
+ LT Debt	7	20	- -	- -
+ LT Borrowings	7	20	- -	- -
+ LT Finance Leases	- -	- -	- -	- -
+ Other LT Liabilities	133	13	- -	1
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	133	13	- -	1
Total Noncurrent Liabilities	140	33	- -	1
Total Liabilities	149	37	25	26
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	4	138	147	174
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	4	138	147	174
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-137	-121	-144	-179
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-132	17	4	-6
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-132	17	4	-6
Total Liabilities & Equity	17	54	29	21
Shares Outstanding	2	2	2	3
Capital Leases - Total	- -	- -	- -	- -
Net Debt	-2	-30	11	6
Net Debt to Equity	1.79	-172.66	293.97	-96.81
Tangible Common Equity Ratio	-791.7	31.97	13.4	-28.21
Current Ratio	1.89	13.3	1.12	0.77
Cash Conversion Cycle	- -	- -	- -	- -
Number of Employees	- -	- -	- -	- -

Cash Flow Statement	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	14	16	-23	-36
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	- -	-40	-6	4
+ Stock-Based Compensation	- -	9	5	5
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	-49	-11	- -
+ Chg in Non-Cash Work Cap	-1	- -	3	2
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	-1	2	1
+ Inc (Dec) in Accts Payable	-1	2	1	1
+ Inc (Dec) in Other	- -	-1	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	14	-25	-26	-30
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	1	- -	- -
+ Disp of Fixed Prod Assets	- -	1	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	-18	15
+ Dec in LT Investment	- -	- -	35	32
+ Inc in LT Investment	- -	- -	-52	-17
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	- -	1	-18	14
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	-2	6	- -	- -
+ Cash From Debt	- -	20	- -	- -
+ Repayments of Debt	-2	-14	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	3	21
+ Increase in Capital Stock	- -	- -	3	21
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Other Financing Activities	- -	53	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	-2	59	3	21
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	12	34	-41	6
Capital Expenditures	- -	- -	- -	- -
EBITDA	16	-32	-32	-34
EBITDA Margin (%)	38.05	- -	- -	- -
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow	14	-25	-26	-30
Free Cash Flow to Firm	15	-23	- -	- -
Free Cash Flow to Equity	- -	-18	-26	-30
Free Cash Flow per Basic Share	- -	- -	- -	- -
Price/Free Cash Flow	- -	- -	- -	- -
Cash Flow to Net Income	0.97	-1.58	1.14	0.83

eFFECTOR Therapeutics, Inc.

Income Statement

Balance Sheet

Cash Flow Statement

Income Statement

Balance Sheet

Cash Flow Statement